Skip to main content

News Archive

News Archive - Scott LaFee

Study Helps Resolve Debate About How Tumors Spread

November 29, 2012

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors.

Biomarking Time

November 21, 2012

In a new study, researchers at the University of California, San Diego School of Medicine, with colleagues elsewhere, describe markers and a model that quantify how aging occurs at the level of genes and molecules, providing not just a more precise way to determine how old someone is, but also perhaps anticipate or treat ailments and diseases that come with the passage of time.

Napoleone Ferrara Awarded The Economist’s 2012 Innovation Award for Bioscience

November 16, 2012

Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow, and with development of new treatments for both cancer and age-related macular degeneration, has been named recipient of The Economist magazine’s 2012 Innovation Award for bioscience.

Roger Tsien, Chemistry, 2008

November 1, 2012

Four years ago, UC San Diego professor of pharmacology, chemistry and biochemistry Roger Tsien, won the Nobel Prize for chemistry (with Martin Chalfie and Osamu Shimomura) for their ground-breaking research in developing green fluorescent proteins derived from a bioluminescent jellyfish.

BPA’s Real Threat May Be After It Has Metabolized

October 4, 2012

Bisphenol A (BPA) is a synthetic chemical widely used in the making of plastic products ranging from bottles and food can linings to toys and water supply lines. When these plastics degrade, BPA is released into the environment and routinely ingested. New research from the University of California, San Diego School of Medicine suggests it’s the metabolic changes that take place once BPA is broken down inside the body that pose the greater health threat.

Blocking Tumor-Induced Inflammation Impacts Cancer Development

October 3, 2012

Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their development and growth.

UCSD-based Cancer Consortium Receives 5-Year, $20 Million Grant Renewal

September 27, 2012

An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for a broad-based effort designed to better understand the pathology of CLL – the most common form of leukemia in the Western world – and develop new drugs and treatments.

New Way of Fighting High Cholesterol Upends Assumptions

September 27, 2012

Atherosclerosis has been presumed to be the consequence of complicated interactions between overabundant cholesterol and resulting inflammation in the heart and blood vessels. Researchers at the University of California, San Diego School of Medicine, with colleagues at institutions across the country, say the relationship is not exactly what it appears, and that a precursor to cholesterol actually suppresses inflammatory response genes. This precursor molecule could provide a new target for drugs designed to treat atherosclerosis.

UC San Diego’s Tsien Honored with First-Ever “Golden Goose Award”

September 13, 2012

Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego School of Medicine who shared the 2008 Nobel Prize in chemistry for his role in helping develop and expand the use of green fluorescent proteins (GFP) was honored today with one of the first-ever “Golden Goose Awards.”

CIRM Funds Six UC San Diego Stem Cell Researchers

September 6, 2012

The governing board of the California Institute for Regenerative Medicine (CIRM) has announced that six investigators from the University of California, San Diego Stem Cell Research program have received a total of more than $7 million in the latest round of CIRM funding. This brings UC San Diego’s total to more than $128 million in CIRM funding since the first awards in 2006.
Category navigation with Social links